Search
for
Sort by
Research 31–60 of 1000+
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
- Pharmacokinetics of two different formulations of finasteride (topical and oral) in male volunteers with androgeneic alopecia
- The effect of St John's Wort on the pharmacokinetics and metabolism of finasteride in healthy men
- The effect of St. John’s wort treatment on finasteride pharmacokinetics and identification of new phase I and phase II metabolites in humans
- Determination of vinflunine in Beagle dog′s plasma by LC-MS and study of its pharmacokinetics
- Determination of finasteride in human plasma and its pharmacokinetics and relative bioavailability by HPLC-electrospray mass spectrometry
- Determination of finasteride by HPLC-MS and study its pharmacokinetics
- Pharmacokinetics and Relative Bioavailability of Finasteride Tablets in Human
- Determination of finasteride in human plasma by LC-MS and its pharmacokinetics
- Determination of Finasteride and Its Pharmacokinetics in Human Plasma by HPLC
- Studies on the pharmacokinetics and bioquivalence of domestic finasteride tablet in healthy volunteers
- Determination of Finasteride in Human Plasma by LC/MS/MS and Study on Its Pharmacokinetics
- Pharmacokinetics of Modified Slow-Release Oral Testosterone over 10 Days in Normal Men with Experimental Hypogonadism
- Pharmacokinetics and Bioconversion of Dehydroepiandrosterone after Application of Dexamethasone in Women with Polycystic Ovary Syndrome
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Pharmacogenetics of the Androgen Metabolic Pathway
- Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Rapid determination of finasteride in human plasma by UPLC–MS/MS and its application to clinical pharmacokinetic study
- Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride
- BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FINASTERIDE, TADALAFIL, AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RAT PLASMA BY USING LC-MS/MS
- Pharmacokinetic study in hairless rat after topical application of finasteride: single and repeated dose
- Single and repeated dose of finasteride topical solution in subjects with androgenetic alopecia: A pharmacokinetic and pharmacodynamic study
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites
- Local Pharmacokinetics and Tolerability of Topically‐Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia